Advertisement
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Malik R, Krockenberger M, O'Brien C, et al. Cryptococcosis. In: Greene CE, ed. Infectious diseases of the dog and cat. 3rd ed. St Louis: Elsevier Saunders, 2006; 584–598.
-
2.
Kwon-Chung KJ. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 1976; 68: 821–833.
-
3.
Ngamskulrungroj P, Gilgado F, Faganello J, et al. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties (Erratum published in PLoS One 2009; 4:doi: 10.1371/annotation/348c3375-3918-4e41-bb8c-27aa15d2bdc4 and PLoS One 2009; 4:doi: 10.1371/annotation/3037bb69–1b8e-4d99-b169-afdf4b74ace2). PLoS One 2009; 4:e5862.
-
4.
Feng X, Yao Z, Ren D, et al. Genotype and mating type analysis of Cryptococcus neoformans and Cryptococcus gattii isolates from China that mainly originated from non-HIV-infected patients. FEMS Yeast Res 2008; 8: 930–938.
-
5.
MacDougall L, Kidd SE, Galanis E, et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis 2007; 13: 42–50.
-
6.
Chong HS, Dagg R, Malik R, et al. In vitro susceptibility of the yeast pathogen Cryptococcus to fluconazole and other azoles varies with molecular genotype. J Clin Microbiol 2010; 48: 4115–4120.
-
7.
Iqbal N, DeBess EE, Wohrle R, et al. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol 2010; 48: 539–544.
-
8.
Byrnes EJ III, Li W, Lewit Y, et al. Emergence and pathogenicity of highly virulent Cryptococcus gattii genotypes in the northwest United States. PLoS Pathog 2010; 6: e1000850.
-
9.
Malik R, Dill-Macky E, Martin P, et al. Cryptococcosis in dogs: a retrospective study of 20 consecutive cases. J Med Vet Mycol 1995; 33: 291–297.
-
10.
Berthelin CF, Bailey CS, Kass PH, et al. Cryptococcus of the nervous system in dogs. Part 1: epidemiologic, clinical and neuropathologic features. Prog Vet Neurol 1994; 5: 88–97.
-
11.
O'Brien CR, Krockenberger MB, Wigney DI, et al. Retrospective study of feline and canine cryptococcosis in Australia from 1981 to 2001: 195 cases. Med Mycol 2004; 42: 449–460.
-
12.
Malik R, Wigney DI, Muir DB, et al. Cryptococcosis in cats: clinical and mycological assessment of 29 cases and evaluation of treatment using orally administered fluconazole. J Med Vet Mycol 1992; 30: 133–144.
-
13.
Blouin P, Cello RM. Experimental ocular cryptococcosis. Preliminary studies in cats and mice. Invest Ophthalmol Vis Sci 1980; 19: 21–30.
-
14.
Newman SJ, Langston CE, Scase TJ. Cryptococcal pyelonephritis in a dog. J Am Vet Med Assoc 2003; 222: 180–183.
-
15.
Malik R, Hunt GB, Bellenger CR, et al. Intra-abdominal cryptococcosis in two dogs. J Small Anim Pract 1999; 40: 387–391.
-
16.
Dixit A, Carroll SF, Qureshi ST. Cryptococcus gattii: an emerging cause of fungal disease in North America [published online ahead of print May 25, 2009]. Interdiscip Perspect Infect Dis. doi:10.1155/2009/840452.
-
17.
Duncan C, Stephen C, Campbell J. Clinical characteristics and predictors of mortality for Cryptococcus gattii infection in dogs and cats of southwestern British Columbia. Can Vet J 2006; 47: 993–998.
-
18.
Malik R, Martin P, Wigney DI, et al. Nasopharyngeal cryptococcosis. Aust Vet J 1997; 75: 483–488.
-
19.
McGill S, Malik R, Saul N, et al. Cryptococcosis in domestic animals in Western Australia: a retrospective study from 1995–2006. Med Mycol 2009; 47: 625–629.
-
20.
Lester SJ, Kowalewich NJ, Bartlett KH, et al. Clinicopathologic features of an unusual outbreak of cryptococcosis in dogs, cats, ferrets, and a bird: 38 cases (January to July 2003). J Am Vet Med Assoc 2004; 225: 1716–1722.
-
21.
Medleau L, Marks MA, Brown J, et al. Clinical evaluation of a cryptococcal antigen latex agglutination test for diagnosis of cryptococcosis in cats. J Am Vet Med Assoc 1990; 196: 1470–1473.
-
22.
Malik R, McPetrie R, Wigney DI, et al. A latex cryptococcal antigen agglutination test for diagnosis and monitoring of therapy for cryptococcosis. Aust Vet J 1996; 74: 358–364.
-
23.
Tanner DC, Weinstein MP, Fedorciw B, et al. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol 1994; 32: 1680–1684.
-
24.
Flatland B, Greene RT, Lappin MR. Clinical and serologic evaluation of cats with cryptococcosis. J Am Vet Med Assoc 1996; 209: 1110–1113.
-
25.
Berthelin CF, Legendre AM, Bailey CS, et al. Cryptococcosis of the nervous system in dogs. Part 2: diagnosis, treatment, monitoring, and prognosis. Prog Vet Neurology 1994; 5: 136–146.
-
26.
Gerds-Grogan S, Dayrell-Hart B. Feline cryptococcosis: a retrospective evaluation. J Am Anim Hosp Assoc 1997; 33: 118–122.
-
27.
Tiches D, Vite CH, Dayrell-Hart B, et al. A case of canine central nervous system cryptococcosis: management with fluconazole. J Am Anim Hosp Assoc 1998; 34: 145–151.
-
28.
Sykes JE, Sturges BK, Cannon MS, et al. Clinical signs, imaging features, neuropathology and outcome in cats and dogs with central nervous system cryptococcosis from California. J Vet Intern Med 2010; 24: 1427–1448.
-
29.
Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol 1982; 15: 535–537.
-
30.
Meyer W, Casteñeda A, Jackson S, et al. Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003; 9: 189–195.
-
31.
Meyer W, Aanensen DM, Boekhout T, et al. Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol 2009; 47: 561–570.
-
32.
Kidd SE, Hagen F, Tscharke RL, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci USA 2004; 101: 17258–17263.
-
33.
Sutton RH. Cryptococcosis in dogs: a report on 6 cases. Aust Vet J 1981; 57: 558–564.
-
34.
Schultz RM, Johnson EG, Wisner ER, et al. Clinicopathologic and diagnostic imaging characteristics of systemic aspergillosis in 30 dogs. J Vet Intern Med 2008; 22: 851–859.
-
35.
Hoang LM, Maguire JA, Doyle P, et al. Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathology. J Med Microbiol 2004; 53: 935–940.
-
36.
Sykes JE, Drazenovich NL, Ball LM, et al. Use of conventional and real-time polymerase chain reaction to determine the epidemiology of hemoplasma infections in anemic and nonanemic cats. J Vet Intern Med 2007; 21: 685–693.
-
37.
Levy JK, Scott HM, Lachtara JL, et al. Seroprevalence of feline leukemia virus and feline immunodeficiency virus infection among cats in North America and risk factors for seropositivity. J Am Vet Med Assoc 2006; 228: 371–376.
-
38.
Byrnes EJ 3rd, Bildfell RJ, Frank SA, et al. Molecular evidence that the range of the Vancouver Island outbreak of Cryptococcus gattii infection has expanded into the Pacific Northwest in the United States. J Infect Dis 2009; 199: 1081–1086.
-
39.
Byrnes EJ 3rd, Bildfell RJ, Dearing PL, et al. Cryptococcus gattii with bimorphic colony types in a dog in western Oregon: additional evidence for expansion of the Vancouver Island outbreak. J Vet Diagn Invest 2009; 21: 133–136.
-
40.
Datta K, Bartlett KH, Marr KA. Cryptococcus gattii: emergence in western North America: exploitation of a novel ecological niche [published online ahead of print Jan 15, 2009]. Interdiscip Perspect Infect Dis. doi:10.1155/2009/176532.
-
41.
Campbell LT, Currie BJ, Krockenberger M, et al. Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot Cell 2005; 4: 1403–1409.
-
42.
Millon L, Barale T, Julliot MC, et al. Interference by hydroxyethyl starch used for vascular filling in latex agglutination test for cryptococcal antigen. J Clin Microbiol 1995; 33: 1917–1919.
-
43.
MacKinnon S, Kane JG, Parker RH. False-positive cryptococcal antigen test and cervical prevertebral abscess. JAMA 1978; 240: 1982–1983.
-
44.
Jacobs GJ, Medleau L, Calvert C, et al. Cryptococcal infection in cats: factors influencing treatment outcome, and results of sequential serum antigen titers in 35 cats. J Vet Intern Med 1997; 11: 1–4.
-
45.
Diamond RD. Cryptococcus neoformans. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. 2nd ed. New York: Churchill Livingstone Inc, 1999; 1980–1989.
-
46.
Labrecque O, Sylvestre D, Messier S. Systemic Cryptococcus albidus infection in a Doberman Pinscher. J Vet Diagn Invest 2005; 17: 598–600.
-
47.
Malik R, Wigney DI, Muir DB, et al. Asymptomatic carriage of Cryptococcus neoformans in the nasal cavity of dogs and cats. J Med Vet Mycol 1997; 35: 27–31.
-
48.
Dewar GJ, Kelly JK. Cryptococcus gattii: an emerging cause of pulmonary nodules. Can Respir J 2008; 15: 153–157.
Advertisement
Clinical features and epidemiology of cryptococcosis in cats and dogs in California: 93 cases (1988–2010)
Abstract
Objective—To compare clinical features of cryptococcosis among cats and dogs in California, determine whether the distribution of involved tissues differs from distribution reported previously in a study in southeastern Australia, and identify Cryptococcus spp isolated from the study population.
Design—Retrospective case series.
Animals—62 cats and 31 dogs with cryptococcosis.
Procedures—Medical records of cats and dogs with cryptococcosis were reviewed. Information collected included geographic location, species, signalment, and tissues or organs involved. Cryptococcosis was confirmed via serology, cytology, histology, or microbial culture, and molecular typing was performed. Odds ratios and 95% confidence intervals were calculated to determine significant associations among variables. Other comparisons were evaluated via χ2 or unpaired t tests.
Results—American Cocker Spaniels were overrepresented, compared with other dog breeds. Serum cryptococcal antigen test results were positive in 51 of 53 cats and 15 of 18 dogs tested. Cryptococcus gattii was more commonly detected in cats (7/9 for which species identification was performed), and Cryptococcus neoformans was more commonly detected in dogs (6/8). Six of 7 C gattii isolates from cats were molecular type VGIII. Distribution of involved tissues was different between cats and dogs in California and between populations of the present study and those of the previously reported Australian study.
Conclusions and Clinical Relevance—Strains of Cryptococcus spp appeared to have host specificity in dogs and cats. Differences in lesion distribution between geographic locations may reflect strain differences or referral bias. Antigen assays alone may not be sufficient for diagnosis of cryptococcosis in cats and dogs.
Contributor Notes
The authors thank Eileen Samitz for providing archived isolates for this study.
Powered by PubFactory